CD19 CAR T-cell therapy (GLPG5101) for relapsed or refractory B-cell non-Hodgkin lymphoma (ATALANTA-1): phase 1 results from a single-arm, multicentre, phase 1/2 study
查看已审核书目、规范引用与获取指引。下载与积分规则登录后查看。
文献信息
题目
CD19 CAR T-cell therapy (GLPG5101) for relapsed or refractory B-cell non-Hodgkin lymphoma (ATALANTA-1): phase 1 results from a single-arm, multicentre, phase 1/2 study
作者
Marie José Kersten, Maria T Kuipers, Pim G N J Mutsaers, Evelyne Willems, Kirsten Saevels, Martin Dreyling, Caron Jacobson, Michael R Bishop, Maarten Zandvliet, Stavros Milatos, Chiara Lobetti-Bodoni, Sandra Blum, Kirsten Van Hoorde, Jigar Desai, Lorenzo Acciarri, Margot J Pont, Anna van Muyden, Omotayo Fasan, Joost S P Vermaat, Sébastien Anguille
Scihuhuan